Equity Profile

CI

The Cigna Group

Health CareHealth Care Services$76.6B

Jul30Thu

Pre-Earnings Brief

UpcomingQ2-2026Pre-Market9:00 AM EDT

Company Snapshot

The Cigna Group (CI) is a major player in the health care sector, providing health insurance and related services. As a significant provider in health care services, Cigna's performance can be influenced by trends in health care costs, regulatory changes, and consumer demand for health services.

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

N/A

Revenue Growth

Revenue growth indicates how well Cigna is expanding its business and attracting new customers.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CI Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+0.80%

Avg Stock Reaction

-4.29%

Last Quarter Recap

In Q1-2026, Cigna reported an EPS of $7.79, beating estimates by 2.18%. However, the stock saw a slight decline of 0.60% the following day, indicating mixed investor sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Cigna's upcoming earnings are cautious, especially given the mixed performance in previous quarters.

Bull Case

If Cigna can demonstrate strong revenue growth and maintain or improve its medical care ratio, it could signal robust operational performance and attract investor confidence.

Bear Case

Conversely, if the company fails to meet EPS expectations or shows signs of increasing costs, it could lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

EPS is a critical measure of profitability, and any significant deviation from expectations could impact investor sentiment.

How is Cigna managing its medical care ratio?

This ratio is essential for understanding the company's cost management and operational efficiency, which can affect future profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Cigna's ability to control costs and grow revenue despite recent challenges in the health care sector.

Supporting Evidence

Cigna has consistently beaten EPS estimates in recent quarters, suggesting underlying strength.

The options market is pricing a larger move than historically realized, indicating potential for a surprise.

Cigna's focus on operational efficiency may not be fully appreciated by analysts.

Key Risk

If the medical care ratio improves significantly, it could lead to a reassessment of Cigna's profitability outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will provide insights into Cigna's ability to manage costs and grow revenue in a competitive market.

Bull Confirmed If

An EPS of $8.00 or higher would confirm strong financial performance and investor confidence.

Bear Confirmed If

An EPS below $7.50 would raise concerns about profitability and operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±8.34%

Historical Avg

±5.6%

Pricing rich

The options market is pricing in a significant move, suggesting that investors are anticipating volatility around the earnings report.

Options are pricing ±8.3% while CI has averaged ±5.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

28.3%

Calls (61K)P/C Ratio: 1.76Puts (39K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cigna beats expectations, history suggests a potential stock increase of around 3.1%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of around 6.7%, reflecting disappointment in the company's performance.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·2 sells

Members

House only

Est. Notional

$3,003.00–$45,000.00

disclosed dollar ranges

Most Active Members

D-CAGilbert CisnerosRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth strategies and market expansion efforts.
2Details on cost management and the medical care ratio for the quarter.
3Insights into regulatory impacts on the health care sector.
4Management's outlook on future earnings and market conditions.
5Any commentary on competitive positioning in the health care services market.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Jul27

DYNBMO

Dyne Therapeutics, Inc.

Insider activity

PreviewView

Jul

Company Snapshot

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of profitability and helps investors gauge the company's financial health.

N/A

Revenue Growth

Revenue growth indicates how well Cigna is expanding its business and attracting new customers.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

CI Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

88%

Avg EPS Surprise

+0.80%

Avg Stock Reaction

-4.29%

Last Quarter Recap

In Q1-2026, Cigna reported an EPS of $7.79, beating estimates by 2.18%. However, the stock saw a slight decline of 0.60% the following day, indicating mixed investor sentiment.

Management Promises & Guidance

Expectations

Wall Street Expectations

Overall, expectations for Cigna's upcoming earnings are cautious, especially given the mixed performance in previous quarters.

Bull Case

If Cigna can demonstrate strong revenue growth and maintain or improve its medical care ratio, it could signal robust operational performance and attract investor confidence.

Bear Case

Conversely, if the company fails to meet EPS expectations or shows signs of increasing costs, it could lead to further declines in stock price.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q2-2026?

EPS is a critical measure of profitability, and any significant deviation from expectations could impact investor sentiment.

How is Cigna managing its medical care ratio?

This ratio is essential for understanding the company's cost management and operational efficiency, which can affect future profitability.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate Cigna's ability to control costs and grow revenue despite recent challenges in the health care sector.

Supporting Evidence

Cigna has consistently beaten EPS estimates in recent quarters, suggesting underlying strength.

The options market is pricing a larger move than historically realized, indicating potential for a surprise.

Cigna's focus on operational efficiency may not be fully appreciated by analysts.

Key Risk

If the medical care ratio improves significantly, it could lead to a reassessment of Cigna's profitability outlook.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is critical as it will provide insights into Cigna's ability to manage costs and grow revenue in a competitive market.

Bull Confirmed If

An EPS of $8.00 or higher would confirm strong financial performance and investor confidence.

Bear Confirmed If

An EPS below $7.50 would raise concerns about profitability and operational challenges.

Pre-Earnings Positioning

Options Market

Implied Move

±8.34%

Historical Avg

±5.6%

Pricing rich

The options market is pricing in a significant move, suggesting that investors are anticipating volatility around the earnings report.

Options are pricing ±8.3% while CI has averaged ±5.6% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

28.3%

Calls (61K)P/C Ratio: 1.76Puts (39K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If Cigna beats expectations, history suggests a potential stock increase of around 3.1%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors await further guidance.

Miss

A miss could lead to a decline of around 6.7%, reflecting disappointment in the company's performance.

Preparation

Congressional Activity

House & Senate STOCK Act disclosures over the trailing 6 months.

Trades

1 buy·2 sells

Members

House only

Est. Notional

$3,003.00–$45,000.00

disclosed dollar ranges

Most Active Members

D-CAGilbert CisnerosRep.
2

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on revenue growth strategies and market expansion efforts.
2Details on cost management and the medical care ratio for the quarter.
3Insights into regulatory impacts on the health care sector.
4Management's outlook on future earnings and market conditions.
5Any commentary on competitive positioning in the health care services market.